Bacteriocin production by Neisseria gonorrhoeae

Area of Science:

• Microbiology
• Bacteriology
• Molecular Biology

Background:

• Neisseria gonorrhoeae is a significant human pathogen.
• Bacterial toxins, such as bacteriocins, play roles in microbial interactions.
• Previous research identified gonococcal inhibitors, but their characteristics varied.

Purpose of the Study:

• To identify and characterize novel growth-inhibitory substances produced by Neisseria gonorrhoeae.
• To determine the nature and properties of the identified inhibitor.
• To investigate the potential of this substance for bacterial typing.

Main Methods:

• Screening of 2,123 Neisseria gonorrhoeae isolates for production of growth inhibitors.
• Testing the inhibitor's sensitivity to trypsin and solubility in chloroform-methanol.
• Assessing the inhibitor's interaction with bovine serum albumin.
• Evaluating the resistance of producing isolates to their own inhibitor.
• Analyzing the correlation between susceptibility to the inhibitor and gonococcal colony type.

Main Results:

• Seventeen isolates (0.8%) produced a diffusible growth-inhibitory substance.
• The inhibitor was destroyed by trypsin, not blocked by bovine serum albumin, and insoluble in chloroform-methanol.
• Producing isolates were resistant to the inhibitor they produced.
• The substance fits the definition of a bacteriocin, designated as gonocin.
• Susceptibility to gonocin was dependent on the colony type of Neisseria gonorrhoeae.

Conclusions:

• A novel bacteriocin, gonocin, produced by Neisseria gonorrhoeae was identified.
• Gonocin exhibits distinct properties compared to previously described gonococcal inhibitors.
• Gonocin's utility for typing Neisseria gonorrhoeae is limited by colony type-dependent susceptibility.